Epidermal growth factor receptor (EGFR) has been particularly well studied in head and neck cancer (HNC) because of its association with the cellular mechanisms involved in tumour progression. High ...
The clinical success of small-molecule vascular disrupting agents (VDAs) depends on their combination with conventional therapies. Scheduling and sequencing remain key issues in the design of ...
Clinically relevant applications, such as somatic variant detection, continue to push the bounds of existing next generation sequencing (NGS) technologies, requiring highly scalable solutions that are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback